EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring the potential mechanism of the active components of Rhizoma Coptidis in tendinopathy treatment applying network pharmacology and molecular docking analysis

Shiqi Ren, Qin Zhu, Ze Yang, Yujing Wang, Zhenkun Li, Haoyu Bian, Jun Tan

Current Pharmaceutical Analysis · 2025-08 · 21 (7) · 337-348

DOI: 10.1016/j.cpan.2025.06.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Pharmaceutical Analysis, 2025-08. Verfasst von Shiqi Ren und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ren, S., Zhu, Q., Yang, Z., Wang, Y., Li, Z., Bian, H., & Tan, J. (2025). Exploring the potential mechanism of the active components of Rhizoma Coptidis in tendinopathy treatment applying network pharmacology and molecular docking analysis. Current Pharmaceutical Analysis, 21(7), 337-348. https://doi.org/10.1016/j.cpan.2025.06.002

Vancouver

Ren S, Zhu Q, Yang Z, Wang Y, Li Z, Bian H, et al. Exploring the potential mechanism of the active components of Rhizoma Coptidis in tendinopathy treatment applying network pharmacology and molecular docking analysis. Current Pharmaceutical Analysis. 2025;21(7):337-348. doi:10.1016/j.cpan.2025.06.002

BibTeX
@article{Ren2025,
  author = {Ren, Shiqi and Zhu, Qin and Yang, Ze and Wang, Yujing and Li, Zhenkun and Bian, Haoyu and Tan, Jun},
  title = {Exploring the potential mechanism of the active components of Rhizoma Coptidis in tendinopathy treatment applying network pharmacology and molecular docking analysis},
  journal = {Current Pharmaceutical Analysis},
  year = {2025},
  volume = {21},
  number = {7},
  pages = {337--348},
  doi = {10.1016/j.cpan.2025.06.002}
}
Kostenlos starten →